Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New 1,3,4‐oxadiazole‐chalcone/benzimidazole hybrids as potent antiproliferative agents
Fatma Fouad Hagar, Samar H. Abbas, Dalia Abdelhamid, et al.
Archiv der Pharmazie (2022) Vol. 356, Iss. 2
Closed Access | Times Cited: 10

Showing 10 citing articles:

Design and Synthesis of New Dihydropyrimidine Derivatives with a Cytotoxic Effect as Dual EGFR/VEGFR-2 Inhibitors
Lamya H. Al-Wahaibi, Ali M. Elshamsy, Taha F. S. Ali, et al.
ACS Omega (2024) Vol. 9, Iss. 32, pp. 34358-34369
Open Access | Times Cited: 9
Benzimidazole-Based Derivatives as Apoptotic Antiproliferative Agents: Design, Synthesis, Docking, and Mechanistic Studies
Bahaa G. M. Youssif, Martha M. Morcoss, Stefan Bräse, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 446-446
Open Access | Times Cited: 6
Rational Design and Synthesis of Isatin‐Chalcone Hybrids Integrated with 1H‐1,2,3‐Triazole: Anti‐Proliferative Profiling and Molecular Docking Insights
Swati, Asif Raza, Shefali Chowdhary, et al.
ChemMedChem (2024) Vol. 19, Iss. 14
Closed Access | Times Cited: 3
Current scenario of chalcone hybrids with antibreast cancer therapeutic applications
Huan Wang, Juanying Zhu, Qianru Zhang, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 5
Closed Access | Times Cited: 2
Benzimidazole‐Containing Compounds as Anticancer Agents
Ulviye Acar Çevik, Ayşen Işık, Betül Kaya, et al.
ChemistrySelect (2024) Vol. 9, Iss. 32
Closed Access | Times Cited: 1
Chalcone/1,3,4-Oxadiazole/Benzimidazole hybrids as novel anti-proliferative agents inducing apoptosis and inhibiting EGFR & BRAFV600E
Fatma Fouad Hagar, Samar H. Abbas, Hesham A. M. Gomaa, et al.
BMC Chemistry (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 4
Recent chemistry and applications of 1,3,4-oxadiazoles
Yaroslav K. Gorbunov, Леонид Л. Ферштат
Advances in heterocyclic chemistry (2023), pp. 1-26
Closed Access | Times Cited: 2
Benzimidazole scaffold as a potent anticancer agent with different mechanisms of action (2016–2023)
Fatma Fouad Hagar, Samar H. Abbas, Eman Atef, et al.
Molecular Diversity (2024)
Open Access
New Oxadiazole/ Benzimidazole Hybrids: Design, Synthesis, and Molecular Docking Studies.
Fatma Fouad Hagar, Samar H. Abbas, Ahmed M. Sayed, et al.
Journal of advanced Biomedical and Pharmaceutical Sciences (2023), pp. 97-106
Open Access | Times Cited: 1
An efficient synthesis of new 3,5‐bis(2‐arylthiazol‐4‐yl)‐1,2,4‐oxadiazole derivatives and their antimicrobial evaluation
Abdul Latif N. Shaikh, Manish Bhoye, Yogesh Nandurkar, et al.
Journal of Heterocyclic Chemistry (2023) Vol. 60, Iss. 6, pp. 976-986
Closed Access
Page 1

Scroll to top